AbbVie to present blood cancer data at EHA 2026

Go back to AbbVie to present blood cancer data at EHA 2026

AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026

June 8, 2026 8:00 AM EDT

Data being presented, including six oral presentations, reinforce AbbVie's leadership and commitment to ongoing research to improve outcomes for people living with blood cancers

NORTH CHICAGO, Ill., June 8, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced it will share new data at the... More